Health ❯Healthcare ❯Drug Development ❯FDA Approval

Tecelra

FDA Approves Adaptimmune's Groundbreaking T-Cell Therapy for Rare Cancer

Tecelra offers new hope for synovial sarcoma patients with limited treatment options